Published by Caoimhe Toman on 1st April 2019
(Sharecast News) - Circassia Pharmaceuticals announced on Monday that the US Food and Drug administration had approved its latest treatment for obstructive pulmonary disease called Duaklir.
URL: http://www.digitallook.com/dl/news/story/28841216/...